Mental DisorderCCOPERNCT05018039
Feasibility and Acceptability of Collaborative Care for People With Musculoskeletal and Mental Problems
A study testing Collaborarive Care Model in people with Mental Disorder and Musculoskeletal Diseases, run by Royal National Orthopaedic Hospital NHS Trust at 2 sites in United Kingdom.
Trial summary
This study aims to implement a feasibility Randomised Controlled Trial to support patients with musculoskeletal problems and a co-existing mental condition, which the intervention will be the implementation of a Collaborative Care Model. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Mental Disorder, Musculoskeletal Diseases
- What is being tested?
- Collaborarive Care Model
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 2 sitesUnited Kingdom
- Study dates
- 30 Jan 2022to 30 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients over 18 years old, with an MSK condition requiring a therapy outpatient appointment.
- Scoring ≥ 20 on the PHQ-ADS.
- Able to provide written informed consent and willing to participate
- Able and willing to complete questionnaires and study assessments
Who cannot join
- Patients who are already receiving treatment for a psychiatric condition from a specialist mental health service.
- Scoring < 20 on the PHQ-ADS.
- Lacking capacity to consent
- Unable or unwilling to complete questionnaires and study assessments
- Participating in other trials
- Participants/ staff
- Clinical staff involved in the treatment of the participants allocated to the intervention group
Trial locations and contacts
2 sites in 1 country.
United Kingdom2 sites, 2 recruiting
- Not yet recruiting
Iva Hauptmannova
Stanmore, London, HA7 4LP
Iva Hauptmannova, MA, 0208 909 5529, iva.hauptmannova@nhs.net
Parashar Ramanuj, MBBS, BSc, 0208 909 5780, p.ramanuj@nhs.net
- Recruiting
Royal National Orthopaedic NHS Trust, Brockley Hill
Stanmore, UK, HA7 4LP
Iva Hauptmannova, MA, 0208 909 5825, iva.hauptmannova@nhs.net
About this study
Official title: A Mixed-methods Randomised Feasibility Trial Comparing a Collaborative Care Model With Standard Care in People With Musculoskeletal and Co-existing Mental Health Conditions.
This study aims to implement a feasibility Randomised Controlled Trial to support patients with musculoskeletal problems and a co-existing mental condition, which the intervention will be the implementation of a Collaborative Care Model.
In England, one in six adults suffers from a mental health condition, such as anxiety or depression. Despite these high numbers, mental health conditions are often unrecognised in physical healthcare settings, including patients with musculoskeletal (MSK) conditions. Patients with both a physical and mental health diagnosis are likely more difficult to treat in comparison to those with just a physical health condition.
Read more
The Collaborative Care Model offers an alternative way of improving musculoskeletal rehabilitation as it takes into consideration both physical and mental health needs. This model involves physical and mental healthcare professionals working together to better identify and manage people with both conditions. Patients are then further supported by a Case Manager who coordinates access to relevant professionals/services following an assessment of both physical and mental health needs.
The investigators propose a feasibility study to assess whether the collaborative care model is beneficial to orthopaedic patients in addressing both physical and mental health needs.
Patients over 18 years old, with an MSK condition attending therapy services at the Royal National Orthopaedic Hospital with a moderate to severe anxiety or depression score, may be eligible. Following informed consent, they will be randomly allocated to either treatment as usual or the intervention group (the collaborative care model with input from a Case Manager). All participants will participate for 6 months with a follow-up on months 3 and 6.
Read the detailed description
Methodology:
The investigators will perform a single-center, mixed methods two-arm parallel-group Randomized Control trial (RCT), comparing the collaborative care intervention in patients with musculoskeletal (MSK) and co-existing mental conditions with usual care.
The study will be carried out at the Therapies Rehabilitation Outpatient setting, at the Royal National Orthopaedic Hospital NHS Trust, Stanmore, London. The duration of the study will be 12 months and the patient's participation will be for 6 months.
Patients will be approached by their attending physician in their routine outpatient clinic appointment regarding whether they would be interested in taking part in this study. As per routine care, this patient group complete PHQ-ADS in their outpatient appointment.
If the patient is interested in taking part and has a PHQ-ADS score of >20, they will be referred to the research team to further discuss participation. The study team will be introduced and available to discuss the study with potential participants. A written patient information sheet (PIS) will be provided. Patients will be given time to process the information should they be interested (a minimum of 24 hours), and consent will be obtained at their next routine appointment, once patients have read and understood the PIS.
Randomised Control Trial:
Following written informed consent, participants will be randomized in a 1:1 ratio (usual care: intervention) which will be undertaken via an online randomization software.
Sample:
It is proposed to recruit 40 patients in total, 20 randomized to each arm of the study. As the study is a feasibility trial, all analyses will be descriptive, with no hypothesis testing. As such no formal sample size calculation has been conducted.
All potentially eligible participants will be recruited through the direct clinical care team. Over 4,000 new patients are attending the therapies appointments annually and they need to complete the PHQ-ADS as a routine of their care.
Data collection:
Data will be collected through questionnaires administrated in clinical, telephone, or video calls according to participant preference and availability. At the eligibility assessment, the PHQ-ADS is collected as a routine of the outpatients setting.
Baseline data will be collected from participants on both arms, including demographic data (age, ethnicity, marital status, highest qualification level, employment status, type of musculoskeletal and mental conditions known and treatment), medical history and current medication using a tailored questionnaire.
The participant will also be asked to complete other quantitative measures at the baseline visit (approx. 50 minutes). This will include self-reported measures of depression, anxiety, pain, and quality of life. These questionnaires will also be completed on month 3 and 6 follow-ups, including any update on the current medication. Participants will stay in the study for a total of 6 months.
Interviews and Focus Group:
Once participant involvement in the study is complete to assess the acceptability of this model of care, participants from the intervention group will be invited to interviews, and health care professionals will be invited for a focus group. The interviews and focus groups will be optional.
Patient interviews will last for approximately 1 hour with some guided topics. The interview is planned to happen face-to-face at the RNOH. Nevertheless, due to COVID restrictions or participant preference, video or telephone interviews will also be available options. Interviews will avoid breaches of confidential material regarding participants' mental health conditions.
The focus group for staff will occur at the end of the RCT. There will be an estimated 6 to 10 members of staff in the focus group, and it will last for approximately 90 minutes. It will take place in RNOH and will be scheduled to suit staff availability. The trial aims to hold face-to-face focus groups but due to COVID restrictions, these focus groups will also be offered on an online platform. It is not expected for staff to attend more than one session, but the staff is welcome to attend another session if they have further feedback to contribute.
This data will give us a chance to understand the experience of being involved in the intervention group. The investigators would like to know the views, thoughts, and experiences of the participants; for example, their opinions on working with a Case Manager, potential advantages, and challenges.
Quantitative data analysis:
The primary analysis will estimate the number of potentially eligible participants, consent and overall uptake. The retention and adherence rates will be calculated in relation to the number of participants recruited. Standard deviations and confidence intervals of clinical outcomes will be calculated and used to determine which outcomes are most sensitive to change which will inform the sample size calculation for a future multi-centre RCT. The staff costs for the intervention group will be calculated using the National Cost index for the NHS.
A statistical analysis plan will be developed by the study statistician supported by SPSS software version 27.
Qualitative data analysis:
Focus groups and interviews will be transcribed in full (ipsis verbis) by an external company, checked for accuracy by a Principal Investigator and then imported into NVIVO version12 qualitative data analysis software, to aid management and indexing of data.
The analysis will begin shortly after data collection starts and framework analysis with Normalization Process Theory (NPT) will be used by the Principal Investigator (Jo). This type of analysis explains processes by which complex interventions become routinely embedded in health care practice. Transcripts from the participants and health care professionals will be analyzed separately. A subset of transcripts will be independently double coded by the other member of the research team and compared. Discrepancies will be discussed and resolved to achieve a coding consensus.
It is aimed to obtain a deeper understanding of the acceptability of the intervention, resources needed, and disclose potential barriers and facilitators from the participants' and health care professionals' points of view.
- Conditions
- Mental Disorder, Musculoskeletal Diseases
- Being tested
- Collaborarive Care Model
- Keywords
- Collaborative Care Model, Case Manager, RCT, Feasibility, Mixed Methods
- Medical subject headings
- Mental Disorders, Musculoskeletal Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Collaborarive Care ModelOther
Collaborative care involves three professionals: a physical health care provider (physiotherapist or occupational therapist), a mental health care provider and a case manager. The case manager will work closely with the patient to identify the mental health support necessary. This may involve appointments with a psychologist or psychiatrist as part of their musculoskeletal treatment.
The case manager will define a treatment plan and organise appointments with the patients and monitor their progress using validated questionnaires, adjusting their mental or physical care support when required. This professional will also monitor patients' attendance and support managing their appointments and routinely update the clinical team on patient progress, and relaying information back to the clinical team. This model of care will work in parallel to the regular musculoskeletal appointments (usual care).
| Study group | Role | What they receive |
|---|---|---|
| Collaborative care model | Experimental | Collaborative care involves three professionals: a physical health care provider (physiotherapist or occupational therapist), a mental health care provider (psychologist or psychiatrist) and a case manager. The case manager will work closely with the patient to identify the mental health support necessary. This may involve appointments with a psychologist or psychiatrist as part of their musculoskeletal treatment.
The case manager will define a treatment plan and organise appointments with the patients and monitor their progress using validated questionnaires, adjusting their mental or physical care support when required. This professional will also monitor patients' attendance and support managing their appointments and routinely update the clinical team on patient progress, and relaying information back to the clinical team. This model of care will work in parallel to the regular musculoskeletal appointments with the physiotherapist and/or occupational therapist (usual care). Receives: Other: Collaborarive Care Model |
| Usal Care | No intervention | Current usual care within musculoskeletal outpatients involves an initial patient assessment by a physiotherapist or occupational therapist (or both) to determine the needs and goals of the patient in relation to their musculoskeletal condition. Clinicians also help to inform, educate, and empower patients to self-manage their rehabilitation where possible. Following this initial assessment, patients are provided with a plan of their therapy treatment. The therapist(s) progress patients exercise, as appropriate. Therapy is most often a 1:1 session but can also include group classes. Physical therapy involves exercise and education, while occupational therapy focuses on practical strategies to perform daily tasks. If the therapists feel that patients require additional support for their mental health problems, they can request this support via the General Practitioner or the hospital mental health services. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of participants
Number of participants consented as a proportion of the number of patients eligible and invited.
Measured: 6 months
Retention
Number of participants ending the trial as a proportion of the number of patients recruited.
Measured: 6 months
Protocol adherence
Percentage of appointments attended as a proportion of booked appointments (%)
Measured: 6 months
Secondary outcomes (7)
Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)
From 0 (no anxiety and depression) to 45 (severe anxiety and depression).
This assessment does not include units.
Measured: pre-intervention, 3 months and 6 months
Resourcing
Resources needed to implement the collaborative care model does not include measurements/units
Usage of concomitant health services - Type of services and frequency of use in absolute numbers
Implementation facilitators and barriers in the intervention arm - qualitative data that will collect via interviews and focus group
Patient and staff acceptability of the intervention - qualitative data that will collect via interviews and focus group
Cost of clinical staff involved on the intervention arm - thorough the number, type and duration of appointments performed by case manager, therapists, and mental health specialist
Measured: month 6
NPRS
From 0 to 10
These assessments do not include units
Measured: pre-intervention, 3 months and 6 months
Pain Disability Index (PDI) to assess pain
From No Disability 0 to Worst Disability 10
These assessments do not include units
Measured: pre-intervention, 3 months and 6 months
Quality of life validated Questionnaire EQ-5D
This scale is numbered from 0 to 100. 100 means the best health you can imagine. 0 means the worst health you can imagine.
This assessment does not include units
Measured: pre-intervention, 3 months and 6 months
Physical health quality assessment validated questionnaire (MSK-HQ)
To assess pain severity, physical function, work interference, social interference, sleep, fatigue, emotional health, physical activity, independence, understanding, confidence to self-manage and overall impact.
The MSK-HQ total score is the sum of items 1-14 from 0 (worst impact) to 56 (no impact).
This assessment does not include units
Measured: pre-intervention, 3 months and 6 months
Global rating of change assessment validated questionnaire (GROC)
To assess self-perceived improvement
From options a very great deal worse to a very great deal better.
This assessment does not include units.
Measured: pre-intervention, 3 months and 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Aug 2021
- Study start30 Jan 2022
- Primary completion30 Jul 2023 (estimated)
- Study completion30 Dec 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Mental DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Royal National Orthopaedic Hospital NHS Trust
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Iva Hauptmannova, Royal National Orthopaedic Hospital NHS Trust
- Investigators
- Parashar Ramanuj, MBBS, Principal investigator, Royal National Orthopaedic Hospital NHS Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05018039
- Sponsor's protocol ID
- 21.06
- Acronym
- CCOPER
- Status last verified
- Oct 2022
- First submitted
- 30 Jun 2021
- Last updated
- 1 Nov 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Teixeira MJC, Ahmed R, Tehrany R, Jaggi A, Ramanuj P. Collaborative care model versus usual care for the management of musculoskeletal and co-existing mental health conditions: a randomised feasibility mixed-methods study. BMJ Open. 2024 Feb 21;14(2):e079707. doi: 10.1136/bmjopen-2023-079707.
PubMed 38387980
Study at a glance
From the registry record, last updated by the sponsor on 1 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Mixed-methods Randomised Feasibility Trial Comparing a Collaborative Care Model With Standard Care in People With Musculoskeletal and Co-existing Mental Health Conditions.
- ClinicalTrials.gov ID
- NCT05018039
- Acronym / sponsor ID
- CCOPER / 21.06
- Conditions
- Mental Disorder, Musculoskeletal Diseases
- Keywords
- Collaborative Care Model, Case Manager, RCT, Feasibility, Mixed Methods
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Royal National Orthopaedic Hospital NHS TrustUniversity, hospital or other
- Study start
- 30 Jan 2022 (actual)
- Primary completion
- 30 Jul 2023 (estimated)
- Study completion
- 30 Dec 2023 (estimated)
- First posted
- 24 Aug 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to implement a feasibility Randomised Controlled Trial to support patients with musculoskeletal problems and a co-existing mental condition, which the intervention will be the implementation of a Collaborative Care Model.
In England, one in six adults suffers from a mental health condition, such as anxiety or depression. Despite these high numbers, mental health conditions are often unrecognised in physical healthcare settings, including patients with musculoskeletal (MSK) conditions. Patients with both a physical and mental health diagnosis are likely more difficult to treat in comparison to those with just a physical health condition.
The Collaborative Care Model offers an alternative way of improving musculoskeletal rehabilitation as it takes into consideration both physical and mental health needs. This model involves physical and mental healthcare professionals working together to better identify and manage people with both conditions. Patients are then further supported by a Case Manager who coordinates access to relevant professionals/services following an assessment of both physical and mental health needs.
The investigators propose a feasibility study to assess whether the collaborative care model is beneficial to orthopaedic patients in addressing both physical and mental health needs.
Patients over 18 years old, with an MSK condition attending therapy services at the Royal National Orthopaedic Hospital with a moderate to severe anxiety or depression score, may be eligible. Following informed consent, they will be randomly allocated to either treatment as usual or the intervention group (the collaborative care model with input from a Case Manager). All participants will participate for 6 months with a follow-up on months 3 and 6.
Detailed description
Methodology:
The investigators will perform a single-center, mixed methods two-arm parallel-group Randomized Control trial (RCT), comparing the collaborative care intervention in patients with musculoskeletal (MSK) and co-existing mental conditions with usual care.
The study will be carried out at the Therapies Rehabilitation Outpatient setting, at the Royal National Orthopaedic Hospital NHS Trust, Stanmore, London. The duration of the study will be 12 months and the patient's participation will be for 6 months.
Patients will be approached by their attending physician in their routine outpatient clinic appointment regarding whether they would be interested in taking part in this study. As per routine care, this patient group complete PHQ-ADS in their outpatient appointment.
If the patient is interested in taking part and has a PHQ-ADS score of >20, they will be referred to the research team to further discuss participation. The study team will be introduced and available to discuss the study with potential participants. A written patient information sheet (PIS) will be provided. Patients will be given time to process the information should they be interested (a minimum of 24 hours), and consent will be obtained at their next routine appointment, once patients have read and understood the PIS.
Randomised Control Trial:
Following written informed consent, participants will be randomized in a 1:1 ratio (usual care: intervention) which will be undertaken via an online randomization software.
Sample:
It is proposed to recruit 40 patients in total, 20 randomized to each arm of the study. As the study is a feasibility trial, all analyses will be descriptive, with no hypothesis testing. As such no formal sample size calculation has been conducted.
All potentially eligible participants will be recruited through the direct clinical care team. Over 4,000 new patients are attending the therapies appointments annually and they need to complete the PHQ-ADS as a routine of their care.
Data collection:
Data will be collected through questionnaires administrated in clinical, telephone, or video calls according to participant preference and availability. At the eligibility assessment, the PHQ-ADS is collected as a routine of the outpatients setting.
Baseline data will be collected from participants on both arms, including demographic data (age, ethnicity, marital status, highest qualification level, employment status, type of musculoskeletal and mental conditions known and treatment), medical history and current medication using a tailored questionnaire.
The participant will also be asked to complete other quantitative measures at the baseline visit (approx. 50 minutes). This will include self-reported measures of depression, anxiety, pain, and quality of life. These questionnaires will also be completed on month 3 and 6 follow-ups, including any update on the current medication. Participants will stay in the study for a total of 6 months.
Interviews and Focus Group:
Once participant involvement in the study is complete to assess the acceptability of this model of care, participants from the intervention group will be invited to interviews, and health care professionals will be invited for a focus group. The interviews and focus groups will be optional.
Patient interviews will last for approximately 1 hour with some guided topics. The interview is planned to happen face-to-face at the RNOH. Nevertheless, due to COVID restrictions or participant preference, video or telephone interviews will also be available options. Interviews will avoid breaches of confidential material regarding participants' mental health conditions.
The focus group for staff will occur at the end of the RCT. There will be an estimated 6 to 10 members of staff in the focus group, and it will last for approximately 90 minutes. It will take place in RNOH and will be scheduled to suit staff availability. The trial aims to hold face-to-face focus groups but due to COVID restrictions, these focus groups will also be offered on an online platform. It is not expected for staff to attend more than one session, but the staff is welcome to attend another session if they have further feedback to contribute.
This data will give us a chance to understand the experience of being involved in the intervention group. The investigators would like to know the views, thoughts, and experiences of the participants; for example, their opinions on working with a Case Manager, potential advantages, and challenges.
Quantitative data analysis:
The primary analysis will estimate the number of potentially eligible participants, consent and overall uptake. The retention and adherence rates will be calculated in relation to the number of participants recruited. Standard deviations and confidence intervals of clinical outcomes will be calculated and used to determine which outcomes are most sensitive to change which will inform the sample size calculation for a future multi-centre RCT. The staff costs for the intervention group will be calculated using the National Cost index for the NHS.
A statistical analysis plan will be developed by the study statistician supported by SPSS software version 27.
Qualitative data analysis:
Focus groups and interviews will be transcribed in full (ipsis verbis) by an external company, checked for accuracy by a Principal Investigator and then imported into NVIVO version12 qualitative data analysis software, to aid management and indexing of data.
The analysis will begin shortly after data collection starts and framework analysis with Normalization Process Theory (NPT) will be used by the Principal Investigator (Jo). This type of analysis explains processes by which complex interventions become routinely embedded in health care practice. Transcripts from the participants and health care professionals will be analyzed separately. A subset of transcripts will be independently double coded by the other member of the research team and compared. Discrepancies will be discussed and resolved to achieve a coding consensus.
It is aimed to obtain a deeper understanding of the acceptability of the intervention, resources needed, and disclose potential barriers and facilitators from the participants' and health care professionals' points of view.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Collaborative care model | Experimental | Other: Collaborarive Care ModelCollaborative care involves three professionals: a physical health care provider (physiotherapist or occupational therapist), a mental health care provider (psychologist or psychiatrist) and a case manager. The case manager will work closely with the patient to identify the mental health support necessary. This may involve appointments with a psychologist or psychiatrist as part of their musculoskeletal treatment. The case manager will define a treatment plan and organise appointments with the patients and monitor their progress using validated questionnaires, adjusting their mental or physical care support when required. This professional will also monitor patients' attendance and support managing their appointments and routinely update the clinical team on patient progress, and relaying information back to the clinical team. This model of care will work in parallel to the regular musculoskeletal appointments with the physiotherapist and/or occupational therapist (usual care). |
| Usal Care | No intervention | –Current usual care within musculoskeletal outpatients involves an initial patient assessment by a physiotherapist or occupational therapist (or both) to determine the needs and goals of the patient in relation to their musculoskeletal condition. Clinicians also help to inform, educate, and empower patients to self-manage their rehabilitation where possible. Following this initial assessment, patients are provided with a plan of their therapy treatment. The therapist(s) progress patients exercise, as appropriate. Therapy is most often a 1:1 session but can also include group classes. Physical therapy involves exercise and education, while occupational therapy focuses on practical strategies to perform daily tasks. If the therapists feel that patients require additional support for their mental health problems, they can request this support via the General Practitioner or the hospital mental health services. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Patients over 18 years old, with an MSK condition requiring a therapy outpatient appointment.
- Scoring ≥ 20 on the PHQ-ADS.
- Able to provide written informed consent and willing to participate
- Able and willing to complete questionnaires and study assessments
Key exclusion criteria (7 listed)
- Patients who are already receiving treatment for a psychiatric condition from a specialist mental health service.
- Scoring < 20 on the PHQ-ADS.
- Lacking capacity to consent
- Unable or unwilling to complete questionnaires and study assessments
- Participating in other trials
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Collaborarive Care ModelCollaborative care involves three professionals: a physical health care provider (physiotherapist or occupational therapist), a mental health care provider and a case manager. The case manager will work closely with the patient to identify the mental health support necessary. This may involve appointments with a psychologist or psychiatrist as part of their musculoskeletal treatment. The case manager will define a treatment plan and organise appointments with the patients and monitor their progress using validated questionnaires, adjusting their mental or physical care support when required. This professional will also monitor patients' attendance and support managing their appointments and routinely update the clinical team on patient progress, and relaying information back to the clinical team. This model of care will work in parallel to the regular musculoskeletal appointments (usual care). | Other | Collaborative care model |
Primary outcome
Number of participants
Time frame: 6 months
Number of participants consented as a proportion of the number of patients eligible and invited.
Retention
Time frame: 6 months
Number of participants ending the trial as a proportion of the number of patients recruited.
Protocol adherence
Time frame: 6 months
Percentage of appointments attended as a proportion of booked appointments (%)
7 secondary outcomes
Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)
Time frame: pre-intervention, 3 months and 6 months
Resourcing
Time frame: month 6
NPRS
Time frame: pre-intervention, 3 months and 6 months
Pain Disability Index (PDI) to assess pain
Time frame: pre-intervention, 3 months and 6 months
Quality of life validated Questionnaire EQ-5D
Time frame: pre-intervention, 3 months and 6 months
Physical health quality assessment validated questionnaire (MSK-HQ)
Time frame: pre-intervention, 3 months and 6 months
Global rating of change assessment validated questionnaire (GROC)
Time frame: pre-intervention, 3 months and 6 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Nov 2022.
- Derived from this study: PubMed 38387980Teixeira MJC, Ahmed R, Tehrany R, Jaggi A, Ramanuj P. Collaborative care model versus usual care for the management of musculoskeletal and co-existing mental health conditions: a randomised feasibility mixed-methods study. BMJ Open. 2024 Feb 21;14(2):e079707. doi: 10.1136/bmjopen-2023-079707.
- Individual participant dataSharing planned: No
Related trials for Mental Disorder
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Parashar Ramanuj, MBBS principal investigator
Royal National Orthopaedic Hospital NHS Trust
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Collaborarive Care Model in people with Mental Disorder and Musculoskeletal Diseases, run by Royal National Orthopaedic Hospital NHS Trust at 2 sites in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 1 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Iva Hauptmannova, MA (0208 909 5529, iva.hauptmannova@nhs.net), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of participants (time frame: 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05018039, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2022.